Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 17% below Graham Number — thin margin of safety
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 14.0% — below-average profitability
- Revenue growing at 12% annually
Elevance Health, Inc. (ELV) is a Financial Services company operating in Hospital & Medical Service Plans, listed on the NYSE , with a market capitalisation of $64.5 billion . Key value metrics: P/E ratio 10.5, P/B ratio 1.47, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Elevance Health, Inc. — Fundamental Analysis Summary
Elevance Health, Inc. (ELV) is trading 17% below its Graham Number of $352.52, offering a thin margin of safety. The stock carries a low trailing P/E ratio of 10.5x.
On financial health, ELV shows a moderate Piotroski F-Score of 6/9, and modest return on equity of 14.0% (sector average: 5.8%), and manageable leverage with a debt-to-equity ratio of 0.73.
StockPik's composite Value Score for ELV is 93/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ELV reports a high gross margin of 89.3% (sector average: 9.2%) and a modest operating margin of 4.3%.
ELV shows revenue growing at 12% year-over-year, with earnings declining at 5%.
ELV pays a modest dividend yield of 2.3%.